Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

Metabolic Effects of Empagliflozin in Heart Failure: A Randomized, Double-Blind, and Placebo-Controlled Trial (Empire HF Metabolic)

Research output: Contribution to journalLetterResearchpeer-review

  • Jesper Jensen
  • Massar Omar
  • Caroline Kistorp
  • Christian Tuxen
  • Ida Gustafsson
  • Lars Køber
  • Finn Gustafsson
  • Jens Faber
  • Julie L Forman
  • Jacob E Møller
  • Morten Schou
View graph of relations
Original languageEnglish
JournalCirculation
Volume143
Issue number22
Pages (from-to)2208-2210
Number of pages3
ISSN0009-7322
DOIs
Publication statusPublished - 1 Jun 2021

    Research areas

  • Body composition, Diabetes mellitus, Empagliflozin, Heart failure, Insulin resistance, Sodium-glucose transporter 2 inhibitors, Type 2

ID: 68355398